Skip to main content
ENVX logo

ENVX · Enovix Corp · Debt

Track ENVX — free
$2.31 +0.06 (+2.67%)
Market Cap
$493.76M
Shares
219.45M
Volume · Oct 20 8.69M Avg daily vol (3M) 7.7M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current debt and lease obligations 2026-07-05 USD 10,593,000 10-Q filed 2026-08-12
Long-term debt, including current maturities 2026-07-05 USD 521,210,000 10-Q filed 2026-08-12
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of long-term debt
USD 216,000
Noncurrent debt carrying amount
USD 520,994,000
Operating lease liabilities 2026-07-05 USD 10,131,000 10-Q filed 2026-08-12
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Noncurrent operating lease liabilities
USD 5,893,000
Short-term borrowings 2026-07-05 USD 10,400,000 10-Q filed 2026-08-12
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

4.75% Convertible Senior Notes due 2030

Note · Enovix Corporation

Reference: 4.75% Convertible Senior Notes due 2030

Active
Original principal
USD 360,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Sep 15, 2030

Last reported interest terms: 4.75% Reported 2025-09-15 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2025-09-10 Original principal USD 360,000,000 Exact source document Parent 8-K filing · 2025-09-15
    On September 10, 2025, Enovix Corporation (the “Company”) completed its previously announced private offering (the “Offering”) of $360 million aggregate principal amount of 4.75% Convertible Senior Notes due 2030 (the “Notes”), which includes the exercise in full of the initial purchasers’ option to purchase up to an additional $60 million principal amount of the Notes. The Notes were issued pursuant to an indenture, dated September 15, 2025 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee. The Notes are general unsecured obligations of the Company and will mature on September 15, 2030, unless earlier converted, redeemed, or repurchased. Interest on the Notes will accrue at a rate of 4.75% per year from September 15, 2025 and will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2026. The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding June 15, 2030, only under the following conditions: (1) during any fiscal quarter commencing after the fiscal quarter ending on December 28, 2025 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the “Measurement Period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Notes for each trading day of the Measurement Period was less than 98% of the product of the last reported sale price of the Common Stock and the conversion rate for the Notes on each such trading day; (3) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after June 15, 2030, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, in integral multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing conditions. Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of Common Stock or a combination of cash and shares of Common Stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture.
    Issuer evidence: On September 10, 2025, Enovix Corporation (the “Company”) completed its previously announced private offering (the “Offering”) of $360 million aggregate principal amount of 4.75% Convertible Senior Notes due 2030 (the “Notes”), which includes the exercise in full of the initial purchasers’ option to purchase up to an additional $60 million principal amount of the Notes. The Notes were issued pursuant to an indenture, dated September 15, 2025 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee. The Notes are general unsecured obligations of the Company and will mature on September 15, 2030, unless earlier converted, redeemed, or repurchased. Interest on the Notes will accrue at a rate of 4.75% per year from September 15, 2025 and will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2026. The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding June 15, 2030, only under the following conditions: (1) during any fiscal quarter commencing after the fiscal quarter ending on December 28, 2025 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the “Measurement Period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Notes for each trading day of the Measurement Period was less than 98% of the product of the last reported sale price of the Common Stock and the conversion rate for the Notes on each such trading day; (3) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after June 15, 2030, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, in integral multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing conditions. Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of Common Stock or a combination of cash and shares of Common Stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture.
    Supporting evidence: On September 10, 2025, Enovix Corporation (the “Company”) completed its previously announced private offering (the “Offering”) of $360 million aggregate principal amount of 4.75% Convertible Senior Notes due 2030 (the “Notes”), which includes the exercise in full of the initial purchasers’ option to purchase up to an additional $60 million principal amount of the Notes. The Notes were issued pursuant to an indenture, dated September 15, 2025 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee. The Notes are general unsecured obligations of the Company and will mature on September 15, 2030, unless earlier converted, redeemed, or repurchased. Interest on the Notes will accrue at a rate of 4.75% per year from September 15, 2025 and will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2026. The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding June 15, 2030, only under the following conditions: (1) during any fiscal quarter commencing after the fiscal quarter ending on December 28, 2025 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the “Measurement Period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Notes for each trading day of the Measurement Period was less than 98% of the product of the last reported sale price of the Common Stock and the conversion rate for the Notes on each such trading day; (3) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after June 15, 2030, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, in integral multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing conditions. Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of Common Stock or a combination of cash and shares of Common Stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture.
    Supporting evidence: On September 10, 2025, Enovix Corporation (the “Company”) completed its previously announced private offering (the “Offering”) of $360 million aggregate principal amount of 4.75% Convertible Senior Notes due 2030 (the “Notes”), which includes the exercise in full of the initial purchasers’ option to purchase up to an additional $60 million principal amount of the Notes. The Notes were issued pursuant to an indenture, dated September 15, 2025 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee. The Notes are general unsecured obligations of the Company and will mature on September 15, 2030, unless earlier converted, redeemed, or repurchased. Interest on the Notes will accrue at a rate of 4.75% per year from September 15, 2025 and will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2026. The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding June 15, 2030, only under the following conditions: (1) during any fiscal quarter commencing after the fiscal quarter ending on December 28, 2025 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the “Measurement Period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Notes for each trading day of the Measurement Period was less than 98% of the product of the last reported sale price of the Common Stock and the conversion rate for the Notes on each such trading day; (3) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after June 15, 2030, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, in integral multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing conditions. Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of Common Stock or a combination of cash and shares of Common Stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture.
Key facts CIK 1828318 CUSIP 293594107 13F (30d) 28 filings 28 filers Visit website Investor relations